2013
DOI: 10.5045/br.2013.48.2.160
|View full text |Cite
|
Sign up to set email alerts
|

Thrombocytopenia caused by low-dose heparin supplementation of parenteral nutrition solution

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 13 publications
0
1
0
Order By: Relevance
“…Thrombotic events due to blood clotting are known to pose a serious problem in cardiovascular disease [45]. Although heparin (a protease inhibitor widely used to delay blood clotting time) has been widely used for this purpose, its continued use often results in the development of thrombocytopenia and immune response [46]. Furthermore, other anticoagulant drugs, such as aspirin and clopidogrel, may lead to serious side effects [47].…”
Section: Anticoagulant Activitymentioning
confidence: 99%
“…Thrombotic events due to blood clotting are known to pose a serious problem in cardiovascular disease [45]. Although heparin (a protease inhibitor widely used to delay blood clotting time) has been widely used for this purpose, its continued use often results in the development of thrombocytopenia and immune response [46]. Furthermore, other anticoagulant drugs, such as aspirin and clopidogrel, may lead to serious side effects [47].…”
Section: Anticoagulant Activitymentioning
confidence: 99%